Join the Oncology Voice Network. Join for Free
The ART of breaking out of your comfort zone
Introversion in MSL overcoming fear in medical science building a personal brand in healthcare networking for introverts success strategies for MSLs

The ART of breaking out of your comfort zone


Share This Article


Summary

In this episode, Cathy Andorfer joins Tom Caravela to discuss the unique challenges and advantages that introverts face within the medical science liaison (MSL) role. They explore the science behind introversion and extroversion, emphasizing the importance of overcoming fear and developing resilience. Cathy shares personal experiences and insights from her upcoming book, offering advice on goal setting, networking, and the significance of building a personal brand while staying authentic. The conversation wraps up with year-end reflections and the importance of being present in one's current role. The episode concludes with closing remarks, future episode teasers, and a reminder to subscribe.

Cathy Andorfer, US Field Medical Dermatology Lead at Bristol Myers Squibb discusses the art of breaking out of your comfort zone

Cathy shares…

πŸ‘‰ The difference between an introvert and an extrovert

πŸ‘‰ How introverts can find success in Medical Affairs

πŸ‘‰ Advice for extroverts on improved engagement

πŸ‘‰ Tips on how to do things that may terrify you

πŸ‘‰ Why “reflection” is so important and how to use it

Click for Source
Introversion in MSL, overcoming fear in medical science, building a personal brand in healthcare, networking for introverts, success strategies for MSLs

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Podcast
The Ideal Roadmap for New MSLs
Partner Avatar MSL Talk: Tom Caravela, Sarah Snyder

The Ideal Roadmap for New MSLs

Article
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring
OVN Avatar B. Gyawali, E. G. E. de Vries, U. Dafni, T. Amaral, J. Barriuso, J. Bogaerts, A. Calles, G. Curigliano, C. Gomez-Roca, B. Kiesewetter, S. Oosting, A. Passaro, G. Pentheroudakis, M. Piccart, F. Roitberg, J. Tabernero, N. Tarazona, D. Trapani, R. Wester, G.

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Explore OVN